Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,171 public trials 6,473 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

NCT07680439

Conditions
Adult Cancer Patients, Brain Diseases, Brain Neoplasms, +26 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Lurie Children's Hospital Chicago, Illinois, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
View Trial Details
Recruiting

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

NCT06441331

Conditions
CNS Tumors, Central Nervous System Neoplasms, GIST, +29 more
Locations
  • The Children's Hospital of Philadelphia (CHOP) Philadelphia, Pennsylvania, United States
  • University of Texas - MD Anderson Cancer Center Houston, Texas, United States
  • Gustave Roussy Cancer Campus Villejuif, France
  • Hospital Universitario Vall d'Hebron - Oncología Médica Barcelona, Spain
View Trial Details
Recruiting

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

NCT06644781

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Baptist Cancer Center Memphis, Tennessee, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View all 132 locations
View Trial Details
Recruiting

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

NCT06177067

Conditions
Acute Leukemia of Ambiguous Lineage, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Rady Children's Hospital San Diego, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Children's Mercy Hospital of Kansas City Kansas City, Missouri, United States
View Trial Details

Related conditions